Yock Young Dan

Dan Yock Young

Appointment(s)
  • Associate Professor, Department of Medicine
  • Adjunct, Cancer Science Institute of Singapore, National University of Singapore
  • Senior Consultant, Division of Gastroenterology and Hepatology, University Medicine Cluster, National University Health System
Administrative Appointment(s)
  • Chair, University Medicine Cluster, National University Health System
  • Head, Department of Medicine, NUS Yong Loo Lin School of Medicine
Joint Appointment(s)
  • Associate Faculty, Genome Institute of Singapore, A*STAR
Academic Qualifications
  • MBBS, National University of Singapore, Singapore
  • MMed (Int Med), National University of Singapore, Singapore
  • MRCP, Royal College of Physicians, United Kingdom
  • FAMS (Gastroenterology), Academy of Medicine, Singapore
  • PhD, National University of Singapore, Singapore
Research Interest(s)
  • Liver Stem Cells
  • Liver Cancer
  • Fatty Liver
Recent Publications
  • 1. Haczeyni, F., Yeh, M. M., Ioannou, G. N., Leclercq, I. A., Goldin, R., Dan, Y. Y., . . . Farrell, G. C. (2018). Mouse models of non-alcoholic steatohepatitis: A reflection on recent literature. Journal of Gastroenterology and Hepatology (Australia), 33(7), 1312-1320. doi:10.1111/jgh.14122.
  • 2. Zhao, C., Lin, J. S., Choolani, M., Dan, Y. Y., Pastorin, G., & Ho, H. K. (2018). Enhanced hepatic differentiation of human amniotic epithelial cells on polyethylene glycol-linked multiwalled carbon nanotube-coated hydrogels. Journal of Tissue Engineering and Regenerative Medicine. doi:10.1002/term.2672
  • 3. Chan, W. K., Treeprasertsuk, S., Imajo, K., Nakajima, A., Seki, Y., Kasama, K., . . . Wong, V. W. S. (2018). Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region—the GO ASIA initiative. Alimentary Pharmacology and Therapeutics, 47(6), 816-825. doi:10.1111/apt.14506.
  • 4. Lu, Y., Fang, J., Zou, L., Cui, L., Liang, X., Lim, S. G., . . . Ong, C. N. (2018). Omega-6-derived oxylipin changes in serum of patients with hepatitis B virus-related liver diseases. Metabolomics, 14(3). doi:10.1007/s11306-018-1326-z.
  • 5. Younossi, Z. M., Chan, H. L. Y., Dan, Y. Y., Lee, M. H., Lim, Y. S., Kruger, E., & Tan, S. C. (2018). Impact of ledipasvir/sofosbuvir on the work productivity of genotype 1 chronic hepatitis C patients in Asia. Journal of Viral Hepatitis, 25(3), 228-235. doi:10.1111/jvh.12808.